Fact-checked by Grok 2 weeks ago

Body mass index


Body mass index (BMI) is a value derived from the weight and height of an adult, serving as an indirect screening tool for body fatness and potential weight-related health conditions. It is calculated using the formula \mathrm{BMI} = \frac{\mathrm{weight\ (kg)}}{\mathrm{height\ (m)}^2}, or in as \mathrm{BMI} = \frac{\mathrm{weight\ (lb)}}{\mathrm{height\ (in)}^2} \times 703. This metric, originally termed the Quetelet Index, was developed in the 1830s by Belgian mathematician, astronomer, and statistician to describe the "average man" in population studies rather than for individual .
BMI categorizes adults as (less than 18.5), normal weight (18.5–24.9), (25.0–29.9), or obese (30.0 or higher), with higher values generally indicating greater risks of conditions such as , , and certain cancers. Large-scale meta-analyses of individual participant data have demonstrated a J-shaped relationship between BMI and all-cause mortality, with the lowest risks typically in the normal weight range (around 22.5–25 kg/m² among never-smokers), increasing risks for both and /obese categories, though the association for overweight is less pronounced than for obesity.30175-1/fulltext) Despite its widespread adoption in clinical practice and public health surveillance for its simplicity and cost-effectiveness, BMI has significant limitations as a measure of adiposity or health. It fails to differentiate between lean mass and fat mass, often misclassifying muscular individuals like athletes as overweight or obese, and does not account for fat distribution (e.g., visceral vs. subcutaneous), age, sex, ethnicity, or frame size, which can lead to inaccuracies in assessing individual health risks. Systematic reviews highlight that while BMI correlates moderately with body fat at the population level, its utility diminishes for personalized assessments, prompting calls for complementary measures like waist circumference or body composition analysis. Nonetheless, empirical evidence from prospective cohorts underscores BMI's value in predicting population-level mortality and morbidity trends, even amid these flaws.

Definition and Calculation

Mathematical Formula

The body mass index (BMI) is computed as body mass in kilograms divided by the square of stature in meters, yielding units of kg/m². This formula, originally termed the Quetelet Index, was formulated by Belgian astronomer and in 1832 to quantify characteristics of l'homme moyen ("the average man") in adult populations. Quetelet derived the height-squared denominator from empirical observations that, among adults of varying statures, body weight tends to scale proportionally to the square of rather than the cube anticipated under strict geometric similarity assumptions for scaled volumes. This scaling reflects average across populations, where taller individuals exhibit relatively slimmer builds, stabilizing the index for comparative purposes in statistical analysis. The index thus serves as a height-normalized descriptor of , independent of individual trajectories. In prevalent in the United States, BMI is equivalently calculated as 703 multiplied by body weight in pounds divided by the square of in inches. This conversion factor arises from unit equivalences: 1 kg ≈ 2.20462 lb and 1 m ≈ 39.3701 in, ensuring numerical consistency with the formulation. Quetelet's approach prioritized population-level averages over individual , positioning BMI as a tool for aggregate human variation rather than personalized assessment.

Categorical Interpretation

The (WHO) established standard BMI categories in the 1990s to classify body weight relative to height based on population-level data associating BMI ranges with health risks. These include (BMI < 18.5), normal weight (BMI 18.5–24.9), overweight (BMI 25.0–29.9), and obesity (BMI ≥ 30.0). The thresholds were derived from actuarial data and epidemiological studies linking BMI distributions to morbidity and mortality patterns in Western populations, serving as statistical cutoffs rather than precise indicators of individual health status. These categories function as proxies for excess adiposity and associated risks, but BMI does not directly measure body fat percentage or composition, limiting its diagnostic utility. Large cohort studies have shown that BMI values above 25 are correlated with increased all-cause mortality, with risks escalating progressively in the obese range, though interpretations must account for confounders like smoking, preexisting conditions, and muscle mass. Thus, categorical interpretations emphasize screening for further assessment rather than standalone diagnoses, as BMI misclassifies adiposity in athletes, elderly individuals, or those with atypical fat distribution. In 2025, expert proposals advanced a revised framework for obesity diagnosis, incorporating waist circumference alongside BMI, effectively reclassifying many in the overweight range (25–<30) as obese if central adiposity is elevated. This shift would increase the proportion of U.S. adults categorized as obese by approximately 18.8%, highlighting ongoing debates over BMI's sufficiency as a sole metric and pushing toward multidimensional risk evaluation grounded in causal adiposity measures. Such adjustments reflect empirical refinements to better align categories with observed metabolic and cardiovascular outcomes in diverse cohorts.

History

Origins in Statistics

The body mass index originated as the Quetelet index, formulated by Belgian astronomer and statistician Lambert Adolphe Jacques Quetelet in the early 1830s as part of his efforts to quantify the "average man" in the field of social physics. Quetelet introduced the index in correspondence in 1832 and elaborated on it in his 1835 treatise Sur l'homme et le développement de ses facultés, ou Essai de physique sociale, where he analyzed body proportions to describe typical human development across populations. His work drew on anthropometric data from European civilians and soldiers, primarily French and Scottish cohorts, to establish empirical norms for height and weight variation without any intent to assess individual health or pathology. Quetelet derived the formula—mass in kilograms divided by the square of height in meters—through algebraic examination of how weight scales with height in adults of similar build, assuming geometric similarity where volume (and thus mass) increases with the square of linear dimensions. This normalization addressed the non-linear relationship observed in his datasets, yielding a dimensionless ratio that minimized variation attributable to stature alone and highlighted deviations from population means. The approach was rooted in descriptive statistics rather than causal inference, aiming to identify l'homme moyen (the average man) as a benchmark for social and demographic analysis. Prior to the 20th century, the Quetelet index served exclusively as a tool in anthropometry and demography for population-level descriptions, such as charting average physique across ages and regions in European samples. It found application in statistical surveys of physical development but made no claims about health outcomes, disease risk, or medical intervention, reflecting Quetelet's focus on probabilistic laws governing human aggregates over individual diagnostics. Medical professionals largely overlooked it during this period, as clinical practice emphasized direct vital signs and symptoms rather than abstracted indices derived from non-clinical data.

Adoption as Health Indicator

In 1972, physiologist revived interest in BMI through the paper "Indices of Relative Weight and Obesity," which evaluated multiple weight-for-height indices across diverse populations and promoted BMI for its simplicity, correlation with body fat percentage, and applicability to epidemiological assessments of health risks, including . Keys' analysis, informed by longitudinal studies like the that established excess weight as an independent predictor of coronary events, positioned BMI as a practical proxy for relative adiposity at the population level rather than for individual diagnostics. The World Health Organization formalized BMI's role in health monitoring during the 1990s, with a 1997 expert consultation establishing standardized cutoffs—BMI of 25–29.9 kg/m² for overweight and ≥30 kg/m² for obesity—to enable consistent global tracking of trends linked to elevated morbidity and mortality. This endorsement drew on meta-analytic evidence associating BMI ≥30 with approximately 1.5- to 2-fold higher all-cause mortality risk relative to normal weight (BMI 18.5–24.9 kg/m²), primarily through comorbidities like hypertension and type 2 diabetes, though effect sizes varied by age and smoking status.30288-2/fulltext) Population data underscored BMI's utility for surveillance, as rising averages correlated with epidemic-level increases in obesity-related burdens across industrialized nations. Following 2000, BMI integrated into major guidelines, such as the U.S. Centers for Disease Control and Prevention's adult obesity definitions and the UK's National Institute for Health and Care Excellence recommendations for risk stratification in primary care. Despite 2020s critiques emphasizing BMI's insensitivity to muscle mass, fat distribution, or fitness—evident in studies showing misclassification for athletes or the elderly—empirical validations reaffirm its effectiveness for aggregate monitoring of obesity epidemics, where U.S. adult prevalence exceeded 40% (BMI ≥30 kg/m²) by 2023 amid stable or rising trends. This persistence reflects causal links from excess adiposity to systemic inflammation and metabolic dysregulation, observable in large cohorts despite individual variances.

Classification Systems

Adult Thresholds

The World Health Organization (WHO) defines adult BMI categories as underweight (<18.5 kg/m²), normal weight (18.5–24.9 kg/m²), overweight (25–29.9 kg/m²), and obesity subdivided into class I (30–34.9 kg/m²), class II (35–39.9 kg/m²), and class III (≥40 kg/m²), with health risks escalating from normal weight as the reference for lowest population-level morbidity and mortality. These thresholds stem from actuarial analyses of large cohorts revealing a J-shaped mortality curve, where all-cause death rates rise below BMI 18.5 kg/m² due to frailty and malnutrition, remain minimal in the normal range, and increase progressively in overweight and obese categories from heightened cardiovascular, metabolic, and cancer risks. Longitudinal studies of never-smokers confirm the nadir of mortality risk at BMI 23–24 kg/m², aligning the upper normal weight segment with optimal longevity in populations free of smoking-related confounders. WHO standards serve as the global benchmark for adult screening, applied across diverse healthcare systems despite critiques that BMI overlooks body composition nuances. In 2025, emerging evidence prompted calls to supplement or replace BMI with body fat percentage metrics, which demonstrate superior prediction of cardiometabolic outcomes in validation cohorts, potentially reclassifying substantial adult populations.

Pediatric and Youth Adjustments

Unlike in adults, where fixed BMI thresholds apply, pediatric assessments require age- and sex-specific adjustments to account for rapid growth phases, including height velocity peaks during puberty that temporarily elevate BMI before stabilization. The Centers for Disease Control and Prevention (CDC) provides BMI-for-age growth charts for U.S. children and adolescents aged 2 to 20 years, derived from National Health and Nutrition Examination Survey (NHANES) data collected between 1963 and 1994, with updates incorporating later measurements. These charts plot BMI against age, using percentile curves to classify weight status: below the 5th percentile indicates underweight, the 5th to less than the 85th percentile healthy weight, the 85th to less than the 95th percentile overweight, and at or above the 95th percentile obesity, with extended charts for severe obesity beyond the 97th percentile employing modified z-score calculations. The World Health Organization (WHO) offers complementary BMI-for-age standards for children aged 5 to 19 years, based on longitudinal data from diverse populations emphasizing breastfed infants and healthy growth patterns, utilizing z-scores where values between -2 and +1 standard deviations (SD) denote normal range, above +1 SD overweight, and above +2 SD obesity. Both systems employ the LMS (lambda-mu-sigma) method to transform raw BMI values into percentiles or z-scores, enabling precise tracking of deviations from population norms while adjusting for skewed distributions in higher ranges. Applying adult cutoffs, such as 25 kg/m² for overweight, would misclassify many healthy growing children, particularly during adolescent growth spurts when BMI naturally fluctuates upward before declining. Empirical data underscore the value of longitudinal percentile tracking, as childhood overweight or obesity exhibits persistence into adulthood, with studies reporting tracking coefficients indicating stability; for instance, obese children aged 3 to 12 years face a 50% to 80% likelihood of adult obesity, rising with parental obesity and decreasing slightly with younger onset age. Recent disruptions, such as COVID-19 lockdowns, accelerated BMI trajectories, with cross-sectional analyses showing average z-score increases of 0.19 to 0.22 in youth, translating to BMI rises of approximately 1 to 2 kg/m², particularly in ages 2 to 11 years, due to reduced physical activity and altered eating patterns. These shifts highlight the utility of percentile monitoring for early detection of adverse trajectories, supporting targeted interventions grounded in observed growth patterns rather than static thresholds.

Ethnic and Regional Variations

The World Health Organization's 2004 expert consultation recommended lower BMI thresholds for Asian populations, classifying overweight as 23–27.5 kg/m² and obesity as ≥27.5 kg/m², due to evidence of elevated risks of type 2 diabetes, cardiovascular disease, and hypertension at BMIs below the standard 25 kg/m² threshold, attributed to higher visceral fat accumulation relative to subcutaneous fat despite lower overall body weight. This adjustment reflects data from multiple Asian cohorts showing risk equivalence to Western populations at standard cutoffs, with observed morbidity rising from BMIs as low as 22 kg/m² in some groups. In Japan, the Japan Society for the Study of Obesity defines obesity as BMI ≥25 kg/m², based on national surveys linking this level to increased metabolic syndrome prevalence, diverging from global norms to account for population-specific fat distribution patterns. Similarly, Singapore's Ministry of Health guidelines adopt overweight as 23.0–27.4 kg/m² and obesity as ≥27.5 kg/m², supported by local studies correlating these levels with higher body fat percentages and diabetes incidence compared to Caucasians at equivalent BMIs. For South Asians, particularly in the UK, ethnicity-specific adjustments propose obesity thresholds around 27.5 kg/m², as standard BMI underestimates diabetes risk; a 2021 analysis of data estimated equivalent risk cutoffs at 23–27.5 kg/m² for overweight and ≥27.5 kg/m² for obesity, potentially misclassifying up to 1 million individuals without ethnic tailoring. In contrast, African Americans exhibit higher lean muscle mass and lower percentage body fat at the same BMI as Caucasians, leading to potential overestimation of obesity risk; NHANES data indicate ~5% lower predicted fat mass in Black adults at BMI 25 kg/m², though overall adiposity-related comorbidities remain elevated due to other factors like insulin resistance. Meta-analyses confirm ethnic variations in BMI-health outcome associations, with Asians facing 10–20% higher relative risks of per BMI unit increase compared to Europeans, underscoring the need for adjusted thresholds to avoid under-detection in high-risk groups. A 2025 study further highlighted racial/ethnic-specific BMI cutoffs for metabolic outcomes, revealing substantial differences (e.g., lower values for Asians and Hispanics predicting equivalent risks to Caucasians), cautioning against universal Western-derived norms that may propagate assessment biases.

Empirical Health Associations

The association between body mass index (BMI) and all-cause mortality follows a J- or U-shaped pattern in large prospective cohort studies and meta-analyses involving millions of participants, with elevated risks at both underweight (BMI <18.5 kg/m²) and obese (BMI ≥30 kg/m²) extremes after adjustment for confounders such as age, smoking, and preexisting conditions. The nadir of mortality risk is generally observed in the normal weight range of 22.5–25 kg/m² among never-smokers and healthy populations, while obesity confers a 20–50% higher risk relative to this reference, as evidenced by dose-response analyses pooling over 230 observational studies. For instance, a 2016 systematic review and meta-analysis reported hazard ratios of 1.18 for BMI 30–35 kg/m² and up to 1.34 for BMI ≥35 kg/m², reflecting progressive increases driven by adiposity-related complications. Some meta-analyses, including a 2024 review of general adult populations, indicate the lowest mortality at BMI 25–30 kg/m² (overweight range), potentially attributable to methodologic factors like reverse causation in sicker individuals or underascertainment of early-life obesity effects, though this finding contrasts with never-smoker subgroups where risks rise modestly above 25 kg/m². Confounder-adjusted models affirm causal contributions from excess adiposity, including visceral fat-mediated inflammation and metabolic dysregulation, which exacerbate cardiovascular and respiratory strain independent of behavioral covariates. Regarding morbidity, obesity (BMI ≥30 kg/m²) approximately doubles the relative risk for major conditions such as cardiovascular disease (CVD), type 2 diabetes, and site-specific cancers compared to normal BMI, based on pooled data from prospective studies tracking incident events. A meta-analysis of over 300,000 adults linked obese BMI categories to elevated coronary artery disease incidence, while similar analyses show risk onset for diabetes accelerating above BMI 25 kg/m² and persisting after multivariable adjustment for lifestyle factors. Cancer risks for obesity-associated types (e.g., endometrial, colorectal) exhibit relative risks of 1.5–2.0, mediated by hyperinsulinemia and adipokine imbalances. In Canada, obesity prevalence rose from 25% in 2009 to 32.7% in 2023, correlating temporally with heightened comorbidity burdens like CVD and diabetes, underscoring population-level impacts.

Evidence from Meta-Analyses

A 2024 meta-analysis of prospective cohort studies involving over 3.9 million adults found a U-shaped association between BMI and all-cause mortality, with the nadir of risk occurring in the overweight range of 25–30 kg/m², and elevated risks both below 18.5 kg/m² and above 30 kg/m², indicating a nonlinear dose-response where deviations from this range independently predict higher mortality after adjusting for confounders like smoking and preexisting conditions. This pattern held across diverse populations, though low BMI risks were partly attributable to reverse causation from smoking and chronic illness, while high BMI risks persisted even after excluding early deaths. Meta-analyses on BMI and COVID-19 outcomes, including an updated 2021 systematic review, consistently link obesity (BMI ≥30 kg/m²) to increased severity, with odds ratios for severe disease or mortality ranging from 1.5 to 2.3 times higher than in normal-weight individuals, driven by mechanisms such as impaired immune response and respiratory mechanics. These findings were robust across hospitalized cohorts globally, with dose-dependent effects showing progressively worse prognosis at BMI levels above 35 kg/m². Subgroup analyses in joint fitness-BMI meta-analyses reveal that cardiorespiratory fitness modifies mortality risks more strongly than BMI alone; a 2025 pooled analysis of over 1 million participants demonstrated that unfit normal-weight individuals (BMI 18.5–24.9 kg/m²) face approximately 1.9-fold higher all-cause mortality compared to fit counterparts, while fit obese individuals (BMI ≥30 kg/m²) exhibit risks comparable to fit normal-weight, underscoring fitness as a dominant predictor independent of adiposity. These associations were consistent across sexes, ages, and follow-up durations exceeding 10 years, with unfit status conferring double the mortality hazard regardless of BMI category. Regarding metabolically healthy obesity (MHO), defined by absence of metabolic syndrome components despite BMI ≥30 kg/m², long-term meta-analyses indicate limited persistence of this phenotype, with over 95% transitioning to metabolically unhealthy states within 10–15 years, accompanied by elevated risks of cardiovascular events (hazard ratio 1.4–1.5) and all-cause mortality compared to metabolically healthy normal-weight individuals. This counters claims of sustained "healthy obesity," as MHO cohorts show dose-response increases in adverse outcomes over extended follow-up, independent of initial metabolic status.

Modifying Influences

Fitness and Activity Levels

Cardiorespiratory fitness (CRF), typically assessed via maximal oxygen uptake (VO2 max), substantially modifies the predictive value of BMI for mortality outcomes, often overriding BMI category in prognostic strength. A 2025 systematic review and meta-analysis published in the British Journal of Sports Medicine examined the joint effects of CRF and BMI on CVD and all-cause mortality across multiple cohorts, finding that higher CRF levels attenuate the elevated risks tied to overweight (BMI 25–29.9 kg/m2) and obesity (BMI ≥30 kg/m2). Specifically, fit overweight and obese individuals showed no statistically significant increase in CVD mortality hazard ratios compared to fit normal-weight (BMI 18.5–24.9 kg/m2) counterparts, while unfit normal-weight individuals exhibited markedly higher risks. This "fitness versus fatness" paradigm is supported by earlier meta-analyses, which report that unfit status doubles all-cause mortality risk irrespective of BMI, whereas fit overweight and obese individuals experience mortality rates akin to fit normal-weight peers—a relative risk reduction of roughly 50% for fit obese versus unfit normal-weight cases in some datasets. For instance, in a cohort of women with suspected ischemic heart disease, physically fit overweight or obese participants faced 40% lower long-term mortality than unfit normal-weight women. These patterns hold across studies like the Aerobics Center Longitudinal Study, where unfit lean men had higher CVD mortality than fit obese men. Mechanistically, elevated VO2 max enhances endothelial function, promoting , reducing , and mitigating atherogenesis, thereby conferring cardioprotection independent of adiposity. Population surveys, including NHANES, reinforce this through objectively measured activity data, showing that higher volumes—particularly vigorous-intensity—diminish the BMI-mortality risk gradient by independently lowering all-cause and CVD event rates, often by 20–50% in adjusted models. Such evidence prioritizes aerobic capacity enhancement over BMI-centric interventions, as sustained activity drives superior outcomes even among those exceeding thresholds.

Body Composition Factors

Visceral adipose tissue, concentrated in (central) distributions, elevates health risks more than equivalent subcutaneous () fat due to direct drainage into the , delivering free fatty acids and pro-inflammatory cytokines like interleukin-6 to the liver, which induces hepatic and systemic metabolic dysfunction. Waist-to-hip ratio, reflecting this central adiposity, predicts mortality and independently of , with meta-analyses showing elevated ratios associated with odds ratios up to 1.98 for infarction risk. Empirical imaging studies confirm visceral fat's causal role in inflammation-driven complications, as opposed to BMI's aggregate mass metric. Lean body mass confounds BMI interpretations, as high muscle volume can inflate BMI without corresponding fat excess, while sarcopenic obesity—high adiposity paired with low muscle—amplifies mortality risks beyond simple obesity. A June 2025 University of Florida analysis of longitudinal data demonstrated BMI's frequent misclassification of muscular individuals as obese or overweight, emphasizing its failure to parse composition quality over total mass. Dual-energy X-ray absorptiometry (DEXA) and MRI validations reveal BMI correlates with body fat percentage at approximately 70% accuracy in population cohorts but overlooks muscle-fat partitioning and ectopic fat deposition. Excess adiposity impairs mitochondrial function through lipid overload, elevating and disrupting , which causally propagates and energy inefficiency independent of BMI thresholds. This mechanism underscores why composition-specific metrics outperform BMI in risk , as validated by tissue-level assays showing reduced respiratory in obese adipose depots.

Applications

Clinical Screening

BMI is employed in clinical settings as an initial screening tool to identify individuals at elevated risk for obesity-associated conditions, facilitating and guiding subsequent diagnostic evaluations. Major guidelines, including those from the (AHA) and (ADA), endorse annual BMI assessment for adults to classify (BMI 25.0–29.9 kg/m²) and (BMI ≥30 kg/m²), with elevated values prompting targeted tests such as HbA1c for glycemic control or lipid panels for cardiovascular risk. This approach leverages BMI's simplicity, requiring only and weight measurements without specialized equipment, enabling routine integration into encounters where it is documented for the majority of eligible patients. Empirical correlations substantiate BMI's utility in predicting metabolic derangements; for instance, higher BMI values are positively associated with elevated total cholesterol, low-density lipoprotein cholesterol, and triglycerides, while inversely linked to cholesterol. Per-unit increases in BMI correspond to measurable shifts in lipid profiles, such as heightened odds of low (approximately 9% increased probability per unit) and dose-dependent rises in cholesterol, particularly in non-obese ranges. These associations support BMI's role in flagging patients for confirmatory labs, as prevalence escalates with BMI categories. Randomized controlled trials demonstrate that BMI-informed screening enables interventions curbing disease progression, as evidenced by the Diabetes Prevention Program (DPP), which targeted overweight adults ( ≥24 kg/m² in certain groups) with and achieved a 58% reduction in incidence through lifestyle modifications yielding ∼4 kg . In this trial, served as a verifiable entry criterion, correlating with improved insulin sensitivity and delayed onset of via sustained behavioral changes. Such outcomes underscore 's practical value in clinical , despite its limitations in distinguishing fat from lean mass, by prioritizing actionable risk stratification over precision adiposity metrics.

Public Health Monitoring

Organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) utilize BMI as a standardized metric for global and national surveillance of overweight and obesity trends, defining obesity as BMI ≥ 30 kg/m². The WHO's Global Health Observatory compiles age-standardized prevalence estimates from member states, revealing that adult obesity more than doubled worldwide from 1990 to 2022, enabling identification of regional epidemics driven by shifts in caloric intake and physical inactivity. In the United States, the CDC's National Health and Nutrition Examination Survey (NHANES) provides direct anthropometric measurements, tracking adult obesity prevalence from approximately 34% in 2009–2010 to 40.3% in 2021–2023, a rise of over 6 percentage points that correlates with increased sedentary behavior and processed food consumption. At the population level, BMI's limitations in distinguishing fat from lean mass are mitigated by aggregation effects, where systematic errors in individual classification cancel out, allowing reliable tracking of mean adiposity changes over time. Meta-analyses of cohort studies confirm that population BMI trends align closely with direct measures of body fatness, such as from , supporting causal inferences about environmental drivers like and dietary shifts. This surveillance data underpins policy responses; for instance, the documented U.S. increase has been linked to annual healthcare costs exceeding $173 billion, prompting targeted interventions in labeling and to address root causes. Recent analyses of post-COVID-19 effects, drawing from longitudinal population data, attribute modest elevations—typically 0.1–0.5 kg/m² on average—to disrupted routines, reduced activity, and altered eating patterns, with prevalence increases of 1–3% in affected cohorts. These findings, observed in studies up to 2025, informed reopenings by highlighting the need for sustained monitoring to reverse transient gains and prevent entrenched rises, demonstrating BMI's role in enabling evidence-based attribution of acute disruptions to long-term trends.

Policy and Economic Contexts

In the , enlistment standards incorporate BMI-derived weight limits, with the setting maximum allowable weights by and that generally cap at BMI values around 30 for younger recruits, such as 212 pounds for a 70-inch-tall individual aged 17-20, to ensure physical readiness. The applies a stricter initial BMI range of 17.5 to 27.5 for applicants, using body composition assessments like tape measurements for those exceeding thresholds to differentiate fat from muscle. These criteria reflect actuarial assessments of obesity-related risks to and , with waivers possible but requiring remediation. Airlines employ average passenger weight assumptions—typically 190-200 pounds including carry-ons—for fuel calculations, derived from periodic surveys correlating with BMI trends, rather than individual BMI mandates. Policies for larger passengers, such as requiring extra seats if encroaching on adjacent space, address operational safety and comfort without direct BMI cutoffs, though debates in the 2020s have explored weight-based pricing to offset fuel costs amid rising average BMIs. Health insurance premiums indirectly scale with BMI through risk pooling, as obesity elevates per-person medical costs by 36-42% compared to normal weight, contributing to higher group rates under frameworks like the , which prohibits explicit surcharges for BMI but allows cost reflections via overall claims data. In some international markets, insurers apply direct loadings of 10-50% for BMI over 30, justified by longitudinal data showing annual cost increases of $69-93 per BMI unit. Obesity, often tracked via BMI, imposes economic burdens equivalent to 0.8-2.4% of GDP in studied Western nations as of 2019, encompassing direct medical expenditures and indirect productivity losses, with projections reaching 3% globally by 2035 absent interventions. Policies like sugar-sweetened beverage taxes, implemented in cities such as since 2017, leverage BMI metrics from epidemiological studies to target caloric intake drivers, yielding modest reductions in youth BMI percentiles (e.g., 0.06-0.12 points prevented increases) and slower adult BMI rises. Workplace wellness initiatives addressing high BMI demonstrate ratios of approximately 3:1, driven by reduced and claims from behavior modifications like activity tracking, as evidenced in employer analyses prioritizing cost-benefit over equity. Amid 2020s debates questioning BMI's standalone policy role—such as American Medical Association guidance to supplement it with adiposity measures—empirical savings from BMI-informed mandates persist, countering pushback with data on net fiscal gains.

Limitations

Fat-Muscle Differentiation Issues

Body mass index (BMI) fails to distinguish between and lean mass, leading to systematic misclassification of muscular individuals as or . This issue is pronounced in athletes, where high muscle density elevates BMI without corresponding fat accumulation; for example, prospective (NFL) players at the scouting combine had an obesity rate of 53.4% by BMI criteria but only 8.9% when assessed via , demonstrating BMI's propensity to overestimate adiposity in those with elevated lean mass. Similar patterns occur in other athletic cohorts, such as players, where BMI classifies over half as obese despite healthy profiles confirmed by skinfold and measures. Comparisons with gold-standard techniques like (DEXA) reveal BMI's moderate correlation with (typically r = 0.7–0.8 in general populations), accounting for roughly 50–64% of variance in fat mass, but with substantial inaccuracies at compositional extremes. In muscular subgroups, BMI overestimates fat content due to its reliance on total mass relative to height squared, ignoring differences—muscle being denser than —resulting in errors of 10–20% or more in adiposity estimates for athletes. This empirical shortfall highlights BMI's causal irrelevance for health outcomes, as lean mass confers metabolic benefits and reduced mortality risk independent of total weight, whereas fat mass drives and disease pathology. Direct body fat measures superiorly predict morbidity and mortality compared to BMI, with a 2025 cohort analysis of over 4,200 U.S. adults showing as a stronger indicator of 15-year all-cause mortality, particularly by identifying risks obscured in normal-weight high-fat individuals. BMI's diagnostic sensitivity for against DEXA-validated fat thresholds approximates 70% in average populations but declines markedly in high-muscle groups, underscoring its inadequacy for precise fat-muscle partitioning.

Demographic and Physiological Variations

In older adults, the BMI associated with lowest all-cause mortality shifts upward compared to younger populations, often falling in the 23.0–29.9 kg/m² range, reflecting adaptations to —age-related muscle loss that increases frailty risks—and the protective role of fat reserves against catabolic states. Studies indicate that classifying elderly individuals as obese using standard BMI thresholds (≥30 kg/m²) may overlook survival benefits from moderate status, as BMI (<22 kg/m²) correlates with higher mortality in this group. Sex differences further complicate BMI interpretation, as women typically carry 10% more total adipose tissue than men at the same BMI due to lower muscle mass and distinct fat distribution patterns favoring gluteofemoral depots. This leads to systematic underestimation of fatness in men and overestimation in women relative to adiposity levels, with analyses showing BMI's correlation with body fat percentage weakening across sexes when muscle variability is unadjusted. Such discrepancies contribute to misclassification rates in health risk assessments, particularly when BMI proxies for metabolic outcomes without sex-specific calibrations. Ethnic variations highlight BMI's non-universal applicability: for Asian populations, standard overweight thresholds (≥25 kg/m²) underestimate cardiometabolic risks, prompting WHO-endorsed lower cutoffs of ≥23 kg/m² for overweight and ≥27.5 kg/m² for obesity to better align with elevated diabetes and cardiovascular disease incidence at moderate BMIs. Conversely, in African American cohorts, higher BMI often links to paradoxically lower mortality—the "obesity paradox"—observed in studies like the Jackson Heart Study, where overweight and class I obesity (BMI 25–34.9 kg/m²) associated with reduced all-cause death rates compared to normal weight, potentially attributable to genetic protections against cachexia, survivor bias, or unmeasured fitness factors. Physiological states like pregnancy and edema transiently inflate BMI without proportional fat accrual: gestational weight gain averages 11–16 kg, incorporating fetal mass (∼3.5 kg), placenta, amniotic fluid, and expanded maternal blood volume, rendering pre- and post-partum BMI comparisons misleading for adiposity tracking. Edema, prevalent in late pregnancy affecting up to 80% of women via venous compression and hormonal fluid retention, adds extracellular water that elevates BMI independently of caloric surplus, necessitating clinical adjustments to avoid conflating hydration status with obesity. These factors underscore the need for contextual modifiers in BMI application to enhance predictive precision across demographics.

Criticisms and Debates

Overreliance and Misclassification Claims

Critics argue that BMI's categorical thresholds—such as overweight at 25.0–29.9 kg/m² and obesity at ≥30 kg/m²—exacerbate overreliance by imposing arbitrary cutoffs that fail to capture individual variability in body composition, leading to widespread misclassification when compared to direct adiposity measures like dual-energy X-ray absorptiometry (DXA). A 2025 debate in the International Journal of Behavioral Nutrition and Physical Activity highlighted BMI's feasibility for broad health assessments but questioned the validity of these categories for precise health interpretations, noting their origins in population averages rather than causal mechanisms of disease risk. Empirical evidence supports claims of significant misclassification, particularly in under-detecting excess adiposity among those with normal or overweight BMI. A study of U.S. adults using DXA found that BMI misclassifies at least 50% of individuals with excess body fat as normal weight or merely overweight, potentially overlooking metabolic risks in "normal weight obesity." Similarly, a 2025 University of Florida analysis of young adults demonstrated BMI's inferiority to body fat percentage in predicting 15-year mortality risk, attributing this to BMI's inability to differentiate fat from lean mass, resulting in error rates exceeding 30% for health outcome forecasts. These findings underscore how individual-level application amplifies errors, as muscular individuals are often falsely flagged as obese while sedentary persons with high visceral fat evade detection. Defenders of BMI counter that such misclassifications reflect misuse rather than invalidity, emphasizing its validated population-level utility where correlations with body fat percentage often exceed 0.7, enabling reliable epidemiological tracking without confounding individual outliers. Overreliance arises primarily from neglecting contextual factors like age, ethnicity, and fitness, which BMI was never designed to isolate, rather than from the metric's core formula. Proponents highlight BMI's advantages as a cost-effective, non-invasive screening tool for public health surveillance, where its simplicity facilitates large-scale data collection and risk stratification at minimal expense compared to advanced imaging. This balance suggests BMI remains empirically defensible for aggregate analyses but warrants supplementary measures for clinical decisions to mitigate category-driven errors.

Cultural Narratives on Obesity

The body positivity movement, which emerged prominently in the 2010s and advocates unconditional self-acceptance of larger body sizes, has been critiqued for minimizing the causal health detriments of obesity in favor of psychological affirmation. Proponents frame obesity as a neutral variation akin to height, but detractors contend this narrative sidesteps mechanistic evidence of adipose tissue dysfunction driving inflammation, insulin resistance, and organ strain, thereby eroding incentives for preventive action. Such cultural shifts, amplified by social media and select academic discourse, reflect institutional tendencies toward equity-focused interpretations over rigorous causal analysis. The "fat but fit" concept posits that physical activity can offset obesity's risks, yet cohort studies demonstrate its rarity and impermanence, with metabolically healthy obesity persisting in under 10% of cases beyond a decade due to progressive cardiometabolic deterioration. Media portrayals normalizing obesity often disregard such data, including epidemiology showing a relative risk of approximately 1.5 for obesity-linked cancers like colorectal and endometrial, independent of fitness levels. These omissions prioritize inclusivity narratives, potentially confounding public understanding of modifiable caloric imbalance as the primary driver. Assertions that BMI-related stigma exacerbates obesity by eroding motivation are challenged by observations that frank acknowledgment of risks correlates with higher engagement in lifestyle interventions, fostering agency rather than resignation. Right-leaning commentaries stress personal accountability, attributing obesity predominantly to behavioral choices over systemic victimhood, aligning with causal models where energy surplus directly precipitates fat accumulation. In contrast, stigma-reduction efforts within body positivity frameworks have shown limited efficacy in prompting sustained weight management, sometimes reinforcing avoidance of accountability. Amid 2020s advocacy to diminish BMI's role in guidelines—citing overreliance concerns—subsequent meta-analyses, including those through 2025, have reinforced obesity's independent contribution to cardiovascular mortality and all-cause death, with hazard ratios escalating linearly beyond BMI thresholds of 25. Body positivity's empirical critiques highlight its failure to attenuate these outcomes, as acceptance rhetoric correlates with stalled public health progress against rising adiposity prevalence.

Alternatives

Direct Adiposity Measures

Direct measures of adiposity quantify body fat percentage (BF%) through techniques that differentiate fat mass from lean mass and bone, offering a more precise assessment than BMI by avoiding conflation with muscle or bone density variations. Common methods include dual-energy X-ray absorptiometry (DEXA), which uses low-dose X-rays to scan and segment body composition with high precision (correlation coefficients of 0.77–0.95 against computed tomography gold standards for fat mass); hydrostatic weighing, which calculates body density via underwater weighing and assumes constant lean tissue density; and bioelectrical impedance analysis (BIA), which estimates fat via electrical conductivity differences between tissues but is susceptible to hydration status errors. These methods demonstrate empirical advantages over BMI in predicting health outcomes, particularly cardiovascular disease (CVD) and mortality. A 2025 study of young adults found BF% superior to BMI for forecasting 15-year all-cause mortality risk, with BF% independently associating after adjusting for confounders like age and smoking. Similarly, BF% correlates more strongly with CVD risk factors such as hypertension and dyslipidemia than BMI, as higher BF% signals metabolic dysfunction even at normal BMI levels. For ectopic fat—lipid accumulation in non-adipose tissues like liver and viscera, which causally drives insulin resistance and CVD via lipotoxicity—these measures highlight total adiposity's role, though visceral-specific quantification (approximable via DEXA regional scans) underscores causality beyond mere excess weight. Obesity thresholds based on BF% are approximately 25% for men and 32% for women, reflecting levels where metabolic risks escalate, independent of height-weight ratios. These cutoffs outperform BMI classifications for individuals with high muscle mass, such as athletes, where BMI often overestimates adiposity risk—e.g., a muscular individual with BMI >30 may have BF% <20%, evading false-positive obesity labeling. Despite superior accuracy (DEXA error margins 1–2% vs. BIA's 3–5%), practical drawbacks include high costs (DEXA scans $100–300), limited accessibility, time requirements (hydrostatic trials demand multiple submersions), and contraindications like pregnancy for DEXA due to radiation. BIA offers portability and low cost ($20–50 devices) but lower reliability in dehydrated or elderly populations. Overall, while direct BF% assessments prioritize causal adiposity burdens like ectopic deposition, their clinical adoption lags BMI due to scalability trade-offs, favoring targeted use in research or high-risk screening.

Geometric and Ratio-Based Indices

Geometric and ratio-based indices seek to refine BMI's mass-to-height-squared ratio by incorporating allometric scaling principles or linear body measurements to better approximate adiposity distribution and health risks. These alternatives address BMI's assumption of uniform scaling, which empirical data indicate underperforms for heterogeneous body compositions, as human dimensions do not expand isometrically with growth or across populations. For instance, BMI Prime normalizes an individual's BMI by dividing it by 25 kg/m², the upper threshold of the healthy BMI range, yielding a value of 1.0 at that boundary to quantify deviation from optimal weight-for-height. The waist-to-height ratio (WHtR), calculated as waist circumference divided by height, exemplifies a ratio-based approach prioritizing central adiposity. A WHtR below 0.5 is associated with lower cardiometabolic risk across adults. Meta-analyses demonstrate WHtR's superior predictive power over BMI for incident type 2 diabetes, with summary relative risks per standard deviation increase of 2.81 (95% CI: 2.60–3.04) for WHtR versus 2.23 (2.12–2.35) for BMI. This edge stems from WHtR's sensitivity to visceral fat accumulation, which correlates more strongly with insulin resistance and cardiovascular endpoints than BMI's aggregate mass metric. A Body Shape Index (ABSI), defined as waist circumference divided by (BMI^{2/3} × height^{1/2}), integrates geometric normalization to isolate abdominal shape independent of overall size. Validation in large cohorts shows ABSI predicts all-cause mortality hazard ratios of 1.13–1.50 per standard deviation increase, persisting after adjusting for BMI and outperforming it in risk stratification. Such indices leverage tape-measurable inputs for clinical feasibility while aligning with causal pathways linking ectopic fat to morbidity, offering verifiable improvements over BMI's cubic scaling limitations where mass scales closer to height^{2.5–3} in empirical models.

Technology-Driven Assessments

Technological advancements in body composition assessment have introduced methods that surpass BMI's inability to differentiate fat from lean mass, incorporating (BIA) in consumer wearables and AI-enhanced imaging for precise fat distribution mapping. BIA devices, integrated into smart scales and watches, estimate body fat percentage, muscle mass, and visceral fat by measuring electrical conductivity through tissues, with multi-frequency models showing correlations of 0.71 to 0.90 against (DEXA) and MRI gold standards for fat mass and skeletal muscle. By 2025, home-based BIA systems via smartphone apps and scales have gained traction for accessibility, correlating over 85% with clinical references in population studies while enabling longitudinal tracking of composition changes. AI-driven tools applied to MRI and CT scans provide causal insights into obesity subtypes, such as visceral adipose tissue accumulation linked to metabolic risks independent of total BMI, by automating segmentation of fat depots with precision exceeding manual methods. These systems detect sarcopenic obesity—concurrent muscle loss and fat gain misclassified as healthy by BMI—through volumetric analysis, revealing prevalence rates up to 4.5% in older adults overlooked by BMI thresholds. Wearable BIA further mitigates BMI's fat-muscle conflation errors, offering subtype differentiation like ectopic fat infiltration, with deep learning models from abdominal MRI achieving high accuracy (r > 0.85) for muscle quality and fat tracking over time. Despite these strengths, technology-driven assessments face limitations including cost barriers—MRI/AI scans averaging $500–$1,500 per session versus BMI's negligible expense—and accuracy variability from factors like status affecting by up to 5% in body fat estimates. Consumer devices exhibit moderate agreement with DEXA in individuals (r ≈ 0.80–0.90), but systematic underestimation occurs in athletes or dehydrated states, rendering them supplementary rather than primary for large-scale epidemiological use where BMI's speed persists. Ongoing validation emphasizes their role in clinical precision over population screening, with proposed as a BMI adjunct but not full replacement due to electrode configuration inconsistencies across devices.

References

  1. [1]
    About Body Mass Index (BMI) - CDC
    May 20, 2024 · BMI = weight (kg) / height (m)2. Although BMI does not directly measure body fat, BMI is moderately to strongly associated with other ...
  2. [2]
    Calculate Your BMI | NHLBI, NIH
    Body mass index (BMI) is a measure of body fat based on height and weight that applies to adult men and women. Your BMI is just one piece of the puzzle.Maintain a Healthy Weight · Eat a Heart-Healthy Diet · Overweight and Obesity
  3. [3]
    Adolphe Quetelet (1796-1874)--the average man and indices of ...
    The best index was the ratio of the weight in kilograms divided by the square of the height in meters, or the Quetelet Index described in 1832.
  4. [4]
    Adult BMI Categories - CDC
    Mar 19, 2024 · BMI categories for adults. BMI is a calculation of a body person's weight (in kilograms) divided by the square of their height (in meters). For ...
  5. [5]
    BMI and all cause mortality: systematic review and non-linear dose ...
    May 4, 2016 · Overweight and obesity is associated with increased risk of all cause mortality and the nadir of the curve was observed at BMI 23-24 among never smokers.Results · Bmi And Mortality Among... · Bmi And All Cause Mortality...<|control11|><|separator|>
  6. [6]
    Strengths and Limitations of BMI in the Diagnosis of Obesity
    Jul 3, 2024 · This review aims to discuss strengths and limitations of body mass index (BMI) ... obesity and overweight: a systematic review and meta-analysis.Bmi: Strengths And... · Other Anthropometric... · Body Composition And Fat...
  7. [7]
    Body Mass Index: Obesity, BMI, and Health: A Critical Review - PMC
    Thus, Quetelet Index = body weight (kilograms) divided by height squared (meters) = BMI. As indicated above, by squaring the height, it reduces the contribution ...
  8. [8]
    Advantages and Limitations of the Body Mass Index (BMI) to Assess ...
    Jun 10, 2024 · ... systematic review and meta-analysis of sarcopenic obesity. Obes. Rev ... Limitations of the Body Mass Index (BMI) to Assess Adult Obesity.
  9. [9]
    Limitations of body mass index to assess body composition due to ...
    Reflective of the obesity rates in the adolescent Hispanic general population [1], half the subjects were either overweight (12/50) or obese (13/50) by BMI% at ...
  10. [10]
    Body mass index and all-cause mortality in a 21st century U.S. ... - NIH
    Jul 5, 2023 · The U.S. prevalence of overweight and obesity has risen dramatically over the last 25 years, with more than half of all adults in the U.S. now ...Bmi, Mortality, And... · Bmi And Mortality In... · Gender And Age Group
  11. [11]
    Mathematical overview of the world's most widely used adiposity index
    Quetelet's Rule ( W ∝ H 2 ), transformed and renamed in the twentieth century to body mass index ( BMI = W / H 2 ), is now a globally applied phenotypic ...
  12. [12]
    Commentary: Origins and evolution of body mass index (BMI)
    Mar 29, 2014 · ... Adolphe Quetelet, under the premise that 'the transverse growth ... ratio of weight (kg) over height (m) squared.2. It was in the 1972 ...<|separator|>
  13. [13]
    Body Mass Index (BMI) Calculator - PhysiologyWeb
    By convention, the calculated BMI has the SI units of kg/m2. If the Imperial (English / U.S.) units of weight (pounds, lb) and height (inches, in) are used, the ...
  14. [14]
    BMI Calculator Body Mass Index
    Aug 1, 2025 · In metric units: BMI = weight (kg) ÷ height2 (meters) · In US units: BMI = weight (lb) ÷ height2 (inches) * 703.
  15. [15]
    Body Mass Index: the dieters' bogeyman discovered by a Belgian ...
    Jan 16, 2014 · Adolphe Quetelet wasn't particularly interested in measuring obesity or promoting diets, but was on a quest to discover 'l'homme moyen', that is ...
  16. [16]
    Moderate and severe thinness, underweight, overweight, obesity
    BMI < 17.0 indicates moderate and severe thinness · BMI < 18.5 indicates underweight · BMI 18.5–24.9 indicates normal weight · BMI ≥ 25.0 indicates overweight · BMI ...
  17. [17]
    The Science, Strengths, and Limitations of Body Mass Index - NCBI
    Body mass index (BMI) is associated with but is not a direct measure of body fat. Therefore, it is useful in screening for obesity, but is not a diagnostic ...
  18. [18]
    Body-mass index and all-cause mortality: individual-participant-data ...
    Both overweight and obesity were associated with increased all-cause mortality. In the BMI range above 25 kg/m2 (ie, above the upper limit of the WHO's ...
  19. [19]
    BMI or not to BMI? debating the value of body mass index as a ...
    Feb 25, 2025 · BMI does not measure body fat but rather is a proxy for body fat by calculating a height to weight ratio. ... Although BMI is not a diagnostic ...
  20. [20]
    Obese Population Swells Under Proposed New Framework
    Jul 8, 2025 · The new diagnostic criteria moved 18.8% of US adults who were previously defined as overweight based on BMI alone (25 to <30) into the obesity category.
  21. [21]
    Experts Pitch Major Overhaul to How Obesity Is Diagnosed
    Jan 14, 2025 · Medical experts from around the globe proposed a more nuanced approach to diagnosing obesity that does not rely exclusively on body mass index (BMI) alone.
  22. [22]
    Adolphe Quetelet (1796–1874)—the average man and indices of ...
    Sep 22, 2007 · It became evident then that the best index was the ratio of the weight in kilograms divided by the square of the height in meters, or the ...Missing: empirical | Show results with:empirical
  23. [23]
    Scaling of human body composition to stature - ScienceDirect.com
    Background: Although Quetelet first reported in 1835 that adult weight scales to the square of stature, limited or no information is available on how ...
  24. [24]
    Weight/height 2 : Mathematical overview of the world's most widely ...
    Oct 10, 2024 · A footnote in Adolphe Quetelet's classic 1835 Treatise on Man described his algebraic analysis of how body weight ( ) varies with height ( ) in adult males and ...
  25. [25]
    Adolphe Quetelet: a statistical method for all - Shells and Pebbles
    Oct 23, 2023 · These statistical methods were demonstrated in his most well-known work Sur l'Homme et le développement de ses facultés (1835), which he himself ...
  26. [26]
    Adolphe Quetelet and the Evolution of Body Mass Index (BMI)
    Mar 18, 2016 · The original ratio came from 19th century Adolphe Quetelet. Source: Used with permission, istock.com, elenabs. There are, of course, more ...
  27. [27]
    The History and Faults of the Body Mass Index and Where to Look ...
    Nov 3, 2023 · Body mass index (BMI) is an anthropometric index that is commonly used in the medical setting and is a factor in assessing various disease risks.
  28. [28]
    Indices of relative weight and obesity - PubMed
    Indices of relative weight and obesity. J Chronic Dis. 1972 Jul 1;25(6):329-43. doi: 10.1016/0021-9681(72)90027-6. Authors. A Keys, F Fidanza, M J Karvonen ...
  29. [29]
    Indices of relative weight and obesity - ScienceDirect.com
    July 1972, Pages 329-343. Journal of Chronic D… Indices of relative weight and obesity. Author links open overlay panelAncel Keys, Flaminio Fidanza, Martti J.
  30. [30]
    The Framingham Heart Study and the Epidemiology of ... - NIH
    Ancel Keys described elevated levels of cholesterol among coronary heart disease patients. ... Obesity as an independent risk factor for cardiovascular disease ...Framingham Risk Scores · Framingham And The... · Metabolic Risk Factors For...
  31. [31]
    Criteria for definition of overweight in transition - ScienceDirect.com
    In 1997, the World Health Organization (WHO) provided further authoritative refinements to the overweight terminology and BMI cutoffs (34). The WHO not only ...
  32. [32]
    Association of All-Cause Mortality With Overweight and Obesity ...
    ... mortality in obesity may predominantly be due to elevated mortality at higher BMI levels. Overweight was associated with significantly lower all-cause mortality ...Table 1 · Table 2 · Figure 3
  33. [33]
    Advantages and Limitations of the Body Mass Index (BMI) to Assess ...
    Jun 10, 2024 · Recent consensus reviews suggest that BMI is a valuable tool for population surveys and primary healthcare screening but has limitations in ...
  34. [34]
    Adult Obesity Prevalence Maps - CDC
    Sep 12, 2024 · Across states and territories. In 2023, all U.S. states and territories had an obesity prevalence higher than 20% (more than 1 in 5 adults).
  35. [35]
    Obesity and Severe Obesity Prevalence in Adults - PubMed
    During August 2021-August 2023, the prevalence of obesity in adults was 40.3%, with no significant differences between men and women. Obesity prevalence was ...
  36. [36]
    Body mass index and all-cause mortality in a 21 st century U.S. ...
    Jul 5, 2023 · In conclusion, our findings suggest that BMI in the overweight range is generally not associated with increased risk of all-cause mortality. Our ...
  37. [37]
    Body mass index (BMI) - World Health Organization (WHO)
    Underweight among adults, BMI < 18.5, prevalence (crude estimate) (%) ... Overweight among adults, BMI >= 25, prevalence (crude estimate) (%) · Obesity among ...
  38. [38]
    Classification of body mass index - UpToDate
    Underweight – BMI <18.5 kg/m2. Normal weight – BMI ≥18.5 to 24.9 kg/m2. Overweight – BMI ≥25 to 29.9 kg/m2. Obesity – BMI ≥30 kg/m2. Obesity class 1 – BMI ...
  39. [39]
    Body-Mass Index and Mortality among 1.46 Million White Adults
    defined as having a body-mass index (BMI) (the weight in kilograms divided by the square of ...<|separator|>
  40. [40]
    Association of BMI with overall and cause-specific mortality
    Oct 30, 2018 · The search string was (“body mass index” OR bmi OR obes*OR overweight) AND (mortality OR death); inclusion and exclusion criteria are listed in ...
  41. [41]
    Obesity and overweight - World Health Organization (WHO)
    May 7, 2025 · The diagnosis of overweight and obesity is made by measuring people's weight and height and by calculating the body mass index (BMI): weight (kg)/ ...
  42. [42]
    Beyond BMI: Scientists propose a new way to define obesity - NPR
    Jan 15, 2025 · The current BMI-based measure of obesity can both overestimate and underestimate how much body fat a person has, explains Dr. Robert Kushner, an ...
  43. [43]
    Study Indicates Dramatic Increase in Percentage of U.S. Adults Who ...
    Oct 15, 2025 · Mass General Brigham researchers studied a new definition of obesity that moves beyond BMI to include measures of body fat distribution.
  44. [44]
    Body Mass Index vs Body Fat Percentage as a Predictor of Mortality ...
    ... overweight and obese. Body mass index (BMI) and body fat percentage (BF%) are 2 commonly used metrics for assessing an individual's body composition and ...
  45. [45]
    CDC Growth Charts
    The growth charts consist of a series of percentile curves that illustrate the distribution of selected body measurements in U.S. children.<|separator|>
  46. [46]
    Comparing the 2000 and 2022 BMI-for-Age Growth Charts - CDC
    Jun 17, 2024 · The 2000 CDC BMI-for-Age Growth Charts have a maximum plottable BMI of 37 kg/m2, which means that they have no percentile lines above the 95th ...Missing: guidelines post-
  47. [47]
    Child and Teen BMI Categories - CDC
    Jun 28, 2024 · Child and teen BMI categories are based on these percentiles, and include underweight, healthy weight, overweight, obesity, and severe obesity.
  48. [48]
    CDC Extended BMI-for-Age Growth Charts
    The 2000 CDC BMI-for-age growth charts, based on data from 1963 to 1980 for most children, do not extend beyond the 97th percentile.Missing: adoption post-
  49. [49]
    Body mass index-for-age (BMI-for-age)
    Child growth standards · Standards · Body mass index-for-age (BMI-for-age) · Length/height-for-age · Weight-for-age · Weight-for-length/height · Head circumference ...
  50. [50]
    Development of a WHO growth reference for school-aged children ...
    At 19 years, the new BMI values at +1 standard deviation (SD) are 25.4 kg/m² for boys and 25.0 kg/m² for girls. These values are equivalent to the overweight ...
  51. [51]
    SAS Program for CDC Growth Charts
    Sep 25, 2024 · 1 Further, the 2000 CDC Growth Charts' BMI z-scores were not intended for use among children and adolescents with extremely high BMI values.Missing: adoption post-
  52. [52]
    Child and Teen BMI Calculator - CDC
    Jun 26, 2024 · For children and teens, BMI is interpreted using sex-specific BMI-for-age percentiles. This calculator reports BMI, BMI percentile, and BMI ...Child and Teen BMI Categories · BMI · Measuring Children’s Height...Missing: methodology | Show results with:methodology
  53. [53]
    Tracking of overweight and obesity from early childhood to ...
    May 10, 2016 · Studies have shown that overweight and obesity tend to be stable (track) from birth, through childhood and adolescence, to adulthood.
  54. [54]
    Predicting Obesity in Young Adulthood from Childhood and Parental ...
    Sep 25, 1997 · Among those who were obese during childhood, the chance of obesity in adulthood ranged from 8 percent for 1- or 2-year-olds without obese ...
  55. [55]
    COVID-19 pandemic-related weight gain in the pediatric population ...
    Overall, age-adapted BMI z-scores increased significantly by 0.22 during the restrictions and remained increased by 0.19 compared to pre-pandemic levels. With ...
  56. [56]
    Changes in BMI During the COVID-19 Pandemic - AAP Publications
    Aug 16, 2022 · A study of children who had their height and weight measured at school revealed accelerated weight gain during the pandemic year compared with ...
  57. [57]
    Body Mass Index in Children Before, During, and After the COVID ...
    Jul 9, 2025 · In this cross-sectional study of changes in iso-BMI in children in Denmark, prevalence of overweight and obesity increased during COVID-19.
  58. [58]
    Body Mass Index Trajectories From Childhood to Adulthood and ...
    Jul 22, 2022 · By age 30, 30% (95% CI: 28, 31) of youths had obesity. Differences in early-life growth persisted into adulthood: 48% (95% CI: 45, 52) of adult ...
  59. [59]
    Appropriate body-mass index for Asian populations and its ...
    Jan 10, 2004 · The cut-off point for observed risk varies from 22 kg/m2 to 25 kg/m2 in different Asian populations; for high risk it varies from 26 kg/m2 to 31 kg/m2.
  60. [60]
    Using appropriate body mass index cut points for overweight ... - NIH
    Using the WHO Asian BMI risk cut points, the 3 categories are 18.5–22.9 kg/m2 (normal weight), 23–27.5 kg/m2 (overweight) and ≥27.5 kg/m2 (obese) (World Health ...
  61. [61]
    Appropriate body-mass index for Asian populations and its ...
    The BMI cut-off point for observed risk in different Asian populations varies from 22 kg/m to 25 kg/m; for high risk it varies from 26kg/m to 31kg/m. Lowering ...
  62. [62]
    Definition, criteria, and core concepts of guidelines for the ... - PubMed
    Mar 28, 2024 · JASSO defines obesity as excessive fat storage in adipose tissue associated with a BMI of ≥25 kg/m2. The threshold BMI of obesity is low as ...
  63. [63]
    Relationship between BMI with percentage body fat and obesity in ...
    Singapore MOH Clinical Practice Guidelines defined overweight as BMI 23·0–27·4 kg/m2 and obesity as BMI ≥27·5 kg/m2. The BF% cut-off points for obesity were set ...
  64. [64]
    Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes ...
    This large sample size enabled us to reliably estimate BMI cutoffs for overweight and obesity for the four main minority ethnic populations currently living in ...
  65. [65]
    BMI of 1 million minority ethnic adults in England wrongly classified
    May 2, 2025 · A million minority ethnic adults are wrongly classified as weighing below the thresholds for being overweight or obese due to official figures not using up-to- ...
  66. [66]
    Why are there race/ethnic differences in adult body mass index ...
    At a BMI of 25 kgm−2 , older NH white men had ~5% greater predicted %fat units than younger NH white men, while younger NH black and Mexican American men had ~2 ...Body Weight Scaled To Height · Body Shape And Composition · Race/ethnic Group Effects
  67. [67]
    Where Do We Go From Here: Impact of Racism & Racial Disparities ...
    Jan 20, 2022 · ... muscle mass and not increased body fat associated with obesity. A BMI Chart that corrects race and ethnicity has been proposed by Dr. Fatima ...
  68. [68]
    Ethnic Differences in the Association Between Body Mass Index and ...
    We conducted a meta-analysis to investigate whether the association between BMI and the risk of T2D differs across ethnic groups. Methods. MEDLINE, EMBASE ...
  69. [69]
    Comparison of racial/ethnic-specific BMI cutoffs for categorizing ...
    Oct 1, 2025 · Establishing a race/ethnicity-tailored classification of three classes of obesity is urgently needed. Keywords: Obesity; Body-Mass Index, BMI; ...
  70. [70]
    Impact of Body Mass Index on All-Cause Mortality in Adults - NIH
    Apr 16, 2024 · Background: Obesity is a risk factor for many diseases, diagnosed by calculating body mass index (BMI). Methods: To find an association ...
  71. [71]
    Obesity and Cardiovascular Disease: A Scientific Statement From ...
    A meta-analysis of >300 000 adults with 18 000 CAD events demonstrated that BMI in the overweight and obese ranges was associated with elevated CAD risk.
  72. [72]
    Association of Body Mass Index with the Risk of Incident Type 2 ...
    Jun 30, 2020 · The risk of developing type 2 diabetes began to increase significantly at the BMI category of 24.2 to 25.0 kg/m 2 for men and 23.6 to 24.5 kg/m 2 for women.
  73. [73]
    Body mass index and cancer risk among adults with and without ...
    Nov 23, 2023 · An additive interaction between obesity (BMI ≥ 30 kg/m2) and CVD with the risk of overall cancer translated into a meta-analytical RERI of 0.28 ...
  74. [74]
    Trends in obesity defined by body mass index among adults before ...
    Jul 14, 2025 · The prevalence of BMI-defined obesity increased from 24.95% in 2009 to 32.69% in 2023 (absolute increase 7.74%).
  75. [75]
    Obesity aggravates COVID‐19: An updated systematic review and ...
    This systematic review and meta‐analysis found that subjects with obesity were more likely to show positive results in the detection of SARS‐CoV‐2. Obese COVID‐ ...<|separator|>
  76. [76]
    Does higher body mass index increase COVID-19 severity? A ...
    A meta-analysis showed that obese people are severely affected by COVID-19 than non-obese people (OR: 2.31, 95% CI: 1.3–4.12) (Yang et al., 2021), which is ...
  77. [77]
    Cardiorespiratory fitness, body mass index and mortality - PubMed
    Feb 20, 2025 · CRF is a strong predictor of CVD and all-cause mortality and attenuates risks associated with overweight and obesity.
  78. [78]
    Fitness vs. fatness on all-cause mortality: a meta-analysis - PubMed
    Oct 11, 2013 · Compared to normal weight-fit individuals, unfit individuals had twice the risk of mortality regardless of BMI. Overweight and obese-fit ...
  79. [79]
    The long-term prognosis of cardiovascular disease and all ... - PubMed
    The meta-analysis confirms a positive association between a metabolically healthy obese phenotype and the risk of CV events.
  80. [80]
    Metabolically Healthy Obesity, Transition to Metabolic Syndrome ...
    Apr 23, 2018 · Dangers and Long-Term Outcomes in Metabolically Healthy Obesity ... metabolically healthy obesity: a systematic review and meta-analysis. J ...
  81. [81]
    Cardiorespiratory fitness, body mass index and mortality
    The major finding of the present meta-analysis was that once CRF was accounted for, there were no significant increases in all-cause or CVD mortality risk for ...
  82. [82]
  83. [83]
    Cardiorespiratory fitness, body composition, and all-cause and ...
    Unfit, lean men also had a higher risk of all-cause and CVD mortality than did men who were fit and obese. We observed similar results for fat and fat-free mass ...<|separator|>
  84. [84]
    Relationships between maximal oxygen uptake and endothelial ...
    This preliminary study suggests that maximal oxygen uptake is independently correlated with endothelial function in healthy non-obese adults.Missing: causal protector
  85. [85]
    The association of cardiorespiratory fitness with endothelial or ...
    Oct 9, 2014 · Maximal oxygen consumption (VO2max) is strongly associated with peripheral vasodilator function as determined by exercise-induced vasodilation.Missing: aerobic causal protector
  86. [86]
    Association between Objectively Measured Physical Activity and ...
    ... physical activity would each be associated with reduced mortality risk. Second, we ... BMI, where height and weight were measured by NHANES technicians.
  87. [87]
    Body-mass Index and Vigorous Physical Activity and the Risk of ...
    We evaluated BMI as both a continuous (per 1 kg/m2 increment) and a categorical (lean, <25, overweight, 25 to 29.9, and obese, ≥30) variable, and vigorous ...
  88. [88]
    Being fit matters more than weight for long-term health, research ...
    Jan 12, 2025 · Normal weight-unfit participants showed 1.92-fold higher all-cause mortality risk, while overweight-unfit and obese-unfit groups exhibited 1.82- ...
  89. [89]
    Role of Body Fat Distribution and the Metabolic Complications of ...
    Visceral fat also releases sufficient IL-6 to increase portal vein IL-6 concentrations, which can affect hepatic metabolism as well. Conclusions. Lower body, ...Missing: android | Show results with:android
  90. [90]
    Visceral fat and metabolic inflammation: the portal theory revisited
    Abdominal (central) obesity strongly correlates with (hepatic) insulin resistance and type 2 diabetes ... Visceral fat and metabolic inflammation: the portal ...Missing: android distribution
  91. [91]
    Body mass index, waist circumference, and waist-hip ratio
    In conclusion, measures of abdominal adiposity, but not BMI, were related to an increased risk of cardiovascular disease mortality.
  92. [92]
    Association between waist-to-hip ratio and risk of myocardial infarction
    Dec 8, 2024 · The meta-analysis showed that an elevated WHR was significantly associated with an increased risk of MI, with a pooled odds ratio (OR) of 1.98.
  93. [93]
    Body Fat Distribution and Risk of Cardiovascular Disease | Circulation
    Sep 4, 2012 · Excess visceral fat accumulation may be causally related to the features of insulin resistance ... distribution, particularly in visceral ...
  94. [94]
    Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality
    Sarcopenic obese men had the highest risk of all-cause mortality but not CVD mortality. Efforts to promote healthy aging should focus on preventing obesity and ...
  95. [95]
    Sarcopenia and Sarcopenic Obesity and Mortality Among Older ...
    Mar 25, 2024 · These findings suggest that sarcopenic obesity may be associated with worse survival, and conducting screening for muscle function may help prevent premature ...
  96. [96]
    Study shows BMI's weakness as a predictor of future health - UF News
    Jun 24, 2025 · Medical researchers say BMI fails in predicting the risk of future death, suggesting the calculation is deeply flawed.
  97. [97]
    The Relationship Between Body Fat Percentage and Body Mass ...
    This study determined the relationship between BMI and body fat (BF)% among adult Nigerians of different ethnic groups residing in an urban setting.
  98. [98]
    Accuracy of body mass index compared to whole-body dual energy ...
    Oct 13, 2023 · Body fat percent was obtained from the whole-body DEXA scan reports and were compared to BMI to evaluate prevalence of obesity. Data was ...Figure 1 · Figure 2 · Table 3
  99. [99]
    Mitochondrial Dysfunction in Obesity - PMC - PubMed Central - NIH
    Nutrient excess leads to mitochondrial dysfunction, which in turn leads to obesity-related pathologies, in part due to the harmful effects of ROS. The recent ...
  100. [100]
    High fat diet consumption results in mitochondrial dysfunction ...
    Excess fat promotes mitochondrial dysfunction in purified oligodendrocytes. •. Chronic high fat diet causes oxidative stress in the brain and spinal cord. •.
  101. [101]
    8. Obesity and Weight Management for the Prevention and ...
    Dec 9, 2024 · This section aims to provide evidence-based recommendations for obesity management, including behavioral, pharmacologic, and surgical interventions,
  102. [102]
    Clinical Assessment and Management of Adult Obesity | Circulation
    Dec 11, 2012 · A desirable or healthy BMI is 18.5 to 24.9 kg/m2; overweight is 25 to 29.9 kg/m2; and obesity is ≥30 kg/m2. Obesity is further subdefined into ...
  103. [103]
    The prevalence of obesity documentation in Primary Care Electronic ...
    The objective of this study is to examine the prevalence of obesity documentation in the patient's problem list for patients with eligible body mass indexes ( ...
  104. [104]
    Correlation between Body Mass Index and Lipid Profile in patients ...
    Studies have shown a direct relationship between increasing BMI and raised TC, LDL-C, and TG and an inverse correlation with HDL-C. This correlation between ...
  105. [105]
    Association of body mass index and lipid profiles - PubMed
    Prior epidemiologic studies have shown that increasing body mass index (BMI) is associated with higher total cholesterol and low-density lipoprotein cholesterol ...
  106. [106]
    [PDF] Associations Between Body Mass Index (BMI) and Dyslipidemia
    Jan 26, 2025 · The relationship between HDL and BMI showed that by one‐unit elevation of. BMI, the probability of having low HDL increased by 9%. A decrease ...
  107. [107]
    Sex differences in the non-linear association between BMI and LDL ...
    Nov 14, 2021 · Quantitatively, in a previous study, LDL-C levels among females with BMI between 27.1 kg/m2 and 30.0 kg/m2 increased by 17 mg/dl compared to ...Study Participants · Statistical Analysis · Subgroup Analysis
  108. [108]
    Impact of Body Mass Index on Coronary Heart Disease Risk Factors ...
    The effect of BMI on high-risk total cholesterol and LDL cholesterol levels was not as strong as that on hypertension, diabetes, elevated triglycerides, and ...Missing: per | Show results with:per
  109. [109]
    The Diabetes Prevention Program and Its Outcomes Study: NIDDK's ...
    Apr 24, 2025 · The lifestyle intervention led to reduced weight, increased self-reported physical activity, and improved estimated insulin sensitivity and ...
  110. [110]
    The Diabetes Prevention Program and Its Outcomes Study: NIDDK's ...
    Compared with placebo, the lifestyle intervention had reduced body weight by ∼4 kg and diabetes development by 58%. Adherence to metformin was ∼70%, and it ...
  111. [111]
    Obesity among adults, BMI >= 30, prevalence (age-standardized ...
    Obesity among adults, BMI >= 30, prevalence (age-standardized estimate) (%). Appears in: Body mass index among adults|; NCD risk factors: BMI ...
  112. [112]
    Obesity and Severe Obesity Prevalence in Adults - CDC
    Sep 24, 2024 · The prevalence of obesity among adults was 40.3% during August 2021–August 2023 (Figure 1, Table 1). The prevalence was 39.2% in men and 41.3% in women.Missing: variations assessment<|control11|><|separator|>
  113. [113]
    Overweight & Obesity Statistics - NIDDK
    More than 2 in 5 adults (42.4%) have obesity.2; About 1 in 11 adults (9.2%) have severe obesity.2. According to 2017–2018 NHANES data.
  114. [114]
    a harmonised meta-analysis of eight prospective cohort studies - PMC
    Dec 7, 2021 · BMI is not a direct measure of body fat and may misclassify ... Worldwide trends in body-mass index, underweight, overweight, and obesity ...
  115. [115]
    Different correlation of body mass index with body fatness and ...
    Mar 1, 2023 · ... BMI and percentage body fat is also different according to race/ethnic groups. ... obesity and overweight: A systematic review and meta-analysis.
  116. [116]
    About Obesity - CDC
    Jan 23, 2024 · Obesity costs the US healthcare system almost $173 billion a year. Obesity also affects the nation's military readiness.
  117. [117]
    Body Mass Index Changes from Before to 3 Years After the COVID ...
    Aug 30, 2025 · Results: In the entire student body, the BMI Z-score in 2021, 1 year after the COVID-19 lockdown, had increased significantly compared with ...
  118. [118]
    Trends in obesity defined by body mass index among adults before ...
    Jul 14, 2025 · The prevalence of BMI-defined obesity increased from 24.95% in 2009 to 32.69% in 2023 (absolute increase 7.74%). The COVID-19 pandemic period ...
  119. [119]
    Impact of the COVID-19 Pandemic on BMI and Obesity among ...
    Oct 17, 2025 · Results: Mean BMI increased from 30.05 pre-COVID to 30.14 during COVID, then declined to 29.96 post-COVID; obesity prevalence followed a similar ...
  120. [120]
    US Army Enlistment Weight Requirements - Military.com
    Jun 24, 2025 · Below is the Army's weight minimum and maximum allowable for recruits to enlist. It is broken down by height and then further into age ...
  121. [121]
    Physical Requirements FAQs - U.S. Air Force
    Waivers are not required for applicant/recruits with permanent ... We utilize a Body Mass Index (BMI) range of 17.5 to 27.5 to determine ...
  122. [122]
    Guide to Passenger Weight Policies on Airlines - iFLY
    Jul 22, 2024 · Every airline has an overweight passenger policy, and passengers are required to accept the rule. Since each airline has its own policy, airline ...
  123. [123]
    'Fat tax': 50% of heavier flyers would pay by their weight - New Atlas
    Dec 18, 2024 · Unsurprisingly, nearly half of respondents (42.1%) under 160 lb were in favor of the unit body weight policy, compared to those weighing over ...<|separator|>
  124. [124]
    Assessing the Impact of Body Mass Index Information on the ... - NIH
    A recent systematic review found that total annual healthcare costs were 36% higher for individuals with obesity as compared to normal weight, and costs were ...Creation Of Bmi Risk Markers · Table 1 · Role Of Bmi In Dx-Based...
  125. [125]
    How Being Overweight Affects Your Health Insurance Policy
    Jun 12, 2025 · If your BMI is over 30, the insurer might add a loading fee, which is an additional charge on your premium. This loading could range from 10% to ...
  126. [126]
    The healthcare costs of increased body mass index–evidence from ...
    Jun 1, 2024 · For females, a unit increase in BMI increased average annual healthcare costs by $68.7 – $69.1 in the multivariable models, and by $92.9 – ...
  127. [127]
    Economic impacts of overweight and obesity: current and future ...
    Nov 4, 2021 · We estimate obesity costs between 0.8% and 2.4% of gross domestic product (GDP) in 2019 in the eight countries in the study. Our projections ...
  128. [128]
    [PDF] Economic impact of overweight and obesity to surpass $4 trillion by ...
    Mar 2, 2023 · Continued failure to improve prevention and treatment could contribute to a total economic impact of US$4.32 trillion by 2035 – nearly 3% of ...<|separator|>
  129. [129]
    City-Level Sugar-Sweetened Beverage Taxes and Youth Body Mass ...
    Jul 31, 2024 · ... BMI percentile and overweight and obesity status. ... tax implementation, the policy may have prevented increases in BMI percentile among youth.
  130. [130]
    Did Philadelphia's soda tax have an impact on people's health?
    Nov 4, 2024 · They found that BMI increased over time in both areas, but the rate at which BMI went up was slower for people in Philadelphia. The new article, ...
  131. [131]
    [PDF] Workplace Wellness Programs Study - U.S. Department of Labor
    It found the ROI to be 3:1 for direct ... When BMI is between 25 and 30, a person is considered overweight; a BMI of 30 or greater indicates obesity.
  132. [132]
    [PDF] Expect Wellness Programs - Partnership for Public Health
    In their analysis, they concluded that there is an average ROI of about 3:1 from worksite health promotion ... wellness programs to reduce health risks within the ...
  133. [133]
    Obesity: Avoid using BMI alone when evaluating patients, say US ...
    Jun 19, 2023 · Doctors should no longer use only body mass index (BMI) when assessing patients for overweight or obesity, the American Medical Association (AMA) decided.Missing: debates mandates 2020s<|control11|><|separator|>
  134. [134]
    New Obesity Definition Challenges Current Use of B.M.I.
    Jan 14, 2025 · Obesity should be assessed in a way that goes beyond the standard measure of body mass index, or BMI, according to a new definition of the condition.
  135. [135]
    Body Composition and Bone Mineral Density of Division 1 ... - NIH
    All positions were classified as overweight or obese based on BMI (>25 kg/m2), yet other than offensive and defensive linemen, all positions had healthy percent ...
  136. [136]
    Body Mass Index (BMI): Still be used? - ScienceDirect.com
    This means that individuals with high muscle mass, such as athletes, may be classified as subjects with overweight or obesity, even if their body fat ...
  137. [137]
    Body Mass Index vs Body Fat Percentage as a Predictor of Mortality ...
    Jul 28, 2025 · Purpose: Body mass index (BMI) is the current standard body composition measurement. We examined BMI vs body fat percentage (BF%) for 15-year ...
  138. [138]
    What is the Optimal Body Mass Index Range for Older Adults? - PMC
    Mar 25, 2022 · In the United States during the 90s, there were approximately 32 million older adults and 26.1% of them had a body mass index (BMI) >30 kg/m2, ...
  139. [139]
    Sex- and Gender-Related Differences in Obesity - PubMed Central
    Jul 4, 2024 · For the same BMI, the percentage of total adipose tissue in females is approximately 10% greater compared to males [11,12]. Although females ...
  140. [140]
    BMI, aka body mass index: What the science says - Stanford Medicine
    Nov 15, 2024 · BMI is an imperfect way to measure body fat in multiple groups given that it does not account for differences across race/ethnic groups, sexes, genders, and ...Bmi, Aka Body Mass Index... · The Debate · What The Science SaysMissing: misclassification | Show results with:misclassification
  141. [141]
    BMI Cut Points to Identify At-Risk Asian Americans for Type 2 ...
    Dec 13, 2014 · BMI cutoffs have been established to identify overweight (BMI ≥25 kg/m2) or obese (BMI ≥30 kg/m2) individuals (12).Overweight/Obesity and Type... · Asian American Studies of... · Conclusions
  142. [142]
    Obesity and overall mortality: findings from the Jackson Heart Study
    Jan 6, 2021 · Overall mortality has been reported to be lower among individuals classified as overweight/obese based on body mass index (BMI, kg/m2) when ...
  143. [143]
    BMI–Mortality Paradox and Fitness in African American and ...
    Others have reported reductions in mortality risk among overweight or obese subjects, a puzzling observation that has been termed the obesity paradox (4–6).
  144. [144]
    Overweight, obesity and excessive weight gain in pregnancy as risk ...
    Women who have a pre‐pregnancy body mass index greater than 25 kg m–2 are more likely than those with a body mass index in the ideal range (20–24.99 kg m–2) to ...
  145. [145]
    Lower-Extremity Edema During Late Pregnancy - Merck Manuals
    Edema is common during late pregnancy. It typically involves the lower extremities but occasionally appears as swelling or puffiness in the face or hands.
  146. [146]
    Lower-Extremity Edema During Late Pregnancy - MSD Manuals
    Edema is common during late pregnancy. It typically involves the lower extremities but occasionally appears as swelling or puffiness in the face or hands.
  147. [147]
    BMI or not to BMI? debating the value of body mass index as a ...
    Feb 25, 2025 · ... BMI or misunderstand the limitations of its application [23, 24]. ... overweight and obesity: a systematic review. Obes Rev. 2018;19(12): ...
  148. [148]
    Accuracy of Body Mass Index to Diagnose Obesity In the US Adult ...
    By using BMI as a marker of obesity, we misclassify ≥ 50% of patients with excess body fat as being normal or just overweight and we miss the opportunity to ...
  149. [149]
    BMI a poor predictor of future health - UF Health
    Jun 24, 2025 · Today, BMI categorizes an individual as either underweight (BMI under 18.5), normal weight (18.5 to 24.9), overweight (25 to 29.9) or obese (30 ...
  150. [150]
    Relationship between Body mass index (BMI) and body fat ...
    Sep 3, 2013 · BMI strongly correlate with BF % estimated by bioelectrical impedance, in this sub population of South Asian adults.
  151. [151]
    Why the body positivity movement risks turning toxic
    Sep 14, 2022 · Critics of body positivity say the movement is not as accepting of all bodies as it claims.
  152. [152]
    The Problem with Body Positivity | Psychology Today
    Jun 13, 2022 · Body positivity messages can be controlling, diminish autonomy, and may cause depression. Forcing positivity can be stressful, and you shouldn' ...
  153. [153]
    Fat and healthy is a myth, new study says - Los Angeles Times
    Dec 2, 2013 · New research finds that even when a person is “metabolically healthy ... obesity from those who argued they were “fat but fit.” The latest ...Missing: debunked | Show results with:debunked
  154. [154]
    'Fat but fit' is not a real thing, obesity study explains - StudyFinds
    The myth of being “fat but fit” is, again, being debunked by a new study. Researchers found that obese individuals, even ...
  155. [155]
    Obesity and Cancer Fact Sheet - NCI
    Jan 28, 2025 · A fact sheet that summarizes the evidence linking overweight and obesity to the risk of various cancers and discusses how obesity affects ...What is obesity? · How might obesity increase... · Does losing weight lower the...
  156. [156]
    How and why weight stigma drives the obesity 'epidemic' and harms ...
    Aug 15, 2018 · Weight stigmatization and bias reduction: perspectives of overweight and obese adults. ... motivation. Stigma Heal. 2018;3(2):85–92 ...
  157. [157]
    Global Trends in Cardiovascular Mortality Attributable to High Body ...
    Oct 7, 2025 · Research has shown that obesity contributes to CVD risk through mechanisms such as hypertension, metabolic dysregulation, and reduced ...
  158. [158]
    Comparison of DXA and CT in the Assessment of Body Composition ...
    Our results demonstrate strong correlations between DXA- and CT-derived body composition measurements in AN, obese, and lean controls (r = 0.77–0.95, P < 0.0001) ...
  159. [159]
    Comparing Methods of Body Composition Analysis
    Apr 8, 2024 · Hydrostatic weighing is a more precise method of measuring overall body fat. Before advanced imaging techniques were used for BCA, hydrostatic ...
  160. [160]
    Body Composition Methods: Comparisons and Interpretation - PMC
    We provide here the most common methods for assessing body composition, including anthropometry, body density, and dual-energy X-ray absorptiometry (DXA).
  161. [161]
    Percent body fat is a better predictor of cardiovascular risk factors ...
    A higher PBF and/or BMI often indicates a higher level of cardiovascular risk (14). However, the relationship between PBF and BMI is not linear (15,16). A high ...<|separator|>
  162. [162]
    Links between ectopic fat and vascular disease in humans - PMC
    In addition to overall obesity, ectopic fat has been found to contribute to cardiovascular disease (CVD). Ectopic fat is fat accumulation in or around specific ...
  163. [163]
    Ideal Body Fat Percentage for Men, Women, How to Calculate It
    Ideal body fat percentage for men ; Athletes, 6% to 13% ; Fitness, 14% to 17% ; Acceptable, 18% to 24% ; Obesity, ≥25% ...How to calculate · For women · For men · BMI calculator
  164. [164]
    DEXA vs. Other Body Fat Testing Methods
    Jun 11, 2025 · DEXA: 19.2-20.8% range. That precision matters when you're making decisions about nutrition, training, and health goals. When Accuracy Becomes ...
  165. [165]
    DEXA vs BIA | Pros and Cons - Nanaimo Body Composition
    In conclusion, while BIA scans can offer a basic assessment of body composition, DEXA scans stand out as the superior choice for those seeking accurate, ...
  166. [166]
    DEXA vs BIA: Which Is the Best for Body Composition Analysis?
    DEXA is the superior choice for the highest accuracy and precision. For a cheaper and more general outlook of your body composition, you could consider a BIA ...
  167. [167]
    DEXA Scan vs. Hydrostatic Weighing for Body Fat Analysis
    Apr 25, 2019 · Hydrostatic weighing is an early technique in body composition analysis that, at the time, used the most sensible concepts to measure body fat and lean mass.
  168. [168]
    Does my BMI look big in this? | University of Oxford
    Jan 16, 2013 · ... BMI relies on is flawed: 'If all three dimensions of a human being scaled equally as they grew, then a formula of the form weight/height3 ...
  169. [169]
    Quetelet's equation, upper weight limits, and BMI prime - PubMed
    Healthy BMI range is 18.5 to 24.9. New equations calculate weight limits above which adults are considered unhealthy. A BMI Prime system relates weight to ...
  170. [170]
    Comparisons of the strength of associations with future type 2 ...
    Dec 1, 2012 · The present meta-analysis showed that WHtR has a modestly but statistically greater importance than BMI and WHR in prediction of diabetes.
  171. [171]
    Comparisons of the Strength of Associations With Future Type 2 ...
    Nov 9, 2012 · The aim of this meta-analysis was to compare the association of waist-to-height ratio (WHtR) with risk of incident diabetes with the ...
  172. [172]
    Diagnostic Accuracy of Waist-to-Height Ratio, Waist Circumference ...
    Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis.
  173. [173]
    A New Body Shape Index Predicts Mortality Hazard Independently ...
    Body shape, as measured by ABSI, appears to be a substantial risk factor for premature mortality in the general population derivable from basic clinical ...
  174. [174]
    A Body Shape Index (ABSI) achieves better mortality risk ... - Nature
    Sep 3, 2020 · We compared the ability of alternative waist indices to complement body mass index (BMI) when assessing all-cause mortality.
  175. [175]
    Now There Are Better Ways Than BMI Charts to Assess Health Risks
    Jan 1, 2024 · The body mass index is flawed, and medicine now has better options to measure obesity. ... A further problem is that BMI is based on height ...
  176. [176]
    Comparison of two bioelectrical impedance analysis devices with ...
    The correlation coefficients between BIA and DXA or MRI ranged from 0.71 to 0.89 for BF, SMM, and VF by HBF 359 and from 0.77 to 0.90 for BF, FFM, and VF by BC ...
  177. [177]
    Application-Based Bioelectrical Impedance Analysis Provides ...
    A recent innovation in body composition assessment is the development of application-based BIA systems, which enable body composition analysis via mobile ...
  178. [178]
    Assessing Body Composition via a Smartphone Computer Vision ...
    Aug 5, 2025 · Smartphone applications utilizing computer vision (CV) offer a promising alternative. This study evaluated the agreement and test-retest ...
  179. [179]
    BMI is BAD, a new study suggests. Here's a better way to measure ...
    Jun 24, 2025 · In BMI world, a body mass between 18.5 and 24.9 is a healthy weight, between 25 and 29.9 is overweight, between 30 and 34.9 is obese, between 35 ...
  180. [180]
    AI in Adipose Imaging: Revolutionizing Visceral Adipose Tissue ...
    Oct 9, 2025 · This review explores the role of artificial intelligence (AI) in visceral adipose tissue (VAT) and ectopic fat imaging.
  181. [181]
    Detecting sarcopenia in obesity: emerging new approaches - NIH
    Jul 18, 2024 · ... BMI-based, ethnic cut-point-specific overweight or obesity. Another community-based study of older adults reported a lower 4.5% prevalence ...
  182. [182]
    Deep learning models for deriving optimised measures of fat and ...
    Jul 17, 2025 · Here we evaluate the accuracy, precision and ability to track change for multiple deep learning (DL) models that quantify fat and muscle mass from abdominal ...
  183. [183]
    “Bioelectrical impedance analysis in managing sarcopenic obesity ...
    The limitation with the use of BMI as a measure of obesity is BMI does ... sarcopenic or nonsarcopenic obese adults. A cross‐sectional study showed ...
  184. [184]
    Accuracy of Bioelectrical Impedance Consumer Devices for ... - NIH
    Because of the lower agreement between foot-to-foot BIA and DXA or MRI for the assessment of body composition in individuals, tetrapolar electrode arrangement ...
  185. [185]
    Reliability and Validity of Contemporary Bioelectrical Impedance ...
    Nov 10, 2022 · Conclusions: Caution should be taken when using BIA devices to assess BF% as devices demonstrated unacceptable agreement compared to DEXA.
  186. [186]
    BMI is a limited measurement for body composition. Could BIA be ...
    Aug 3, 2025 · BMI is still commonly used to assess obesity even though research has shown it's not necessarily a reliable metric. A new study proposes doctors ...
  187. [187]
    Real-world assessment of Multi-Frequency Bioelectrical Impedance ...
    Sep 16, 2025 · Now there is adequate scientific support to replace BMI with BIA as a better assessment of actual body composition.Missing: driven alternatives